October 2025's Top European Growth Stocks With High Insider Ownership

Simply Wall St

As European markets navigate a landscape marked by stable interest rate policies and modest economic growth, investors are increasingly attentive to insider ownership as a potential indicator of company confidence and alignment with shareholder interests. In this context, identifying growth companies with high insider ownership can be particularly appealing, as it suggests that those closest to the business are invested in its success amidst ongoing market uncertainties.

Top 10 Growth Companies With High Insider Ownership In Europe

NameInsider OwnershipEarnings Growth
XTPL (WSE:XTP)23.3%107.3%
Pharma Mar (BME:PHM)11.9%44.2%
MedinCell (ENXTPA:MEDCL)12.5%90.7%
KebNi (OM:KEBNI B)38%63.7%
Elliptic Laboratories (OB:ELABS)24.4%97.5%
CTT Systems (OM:CTT)17.5%37.9%
Circus (XTRA:CA1)24.5%67.1%
CD Projekt (WSE:CDR)29.7%43.5%
Bonesupport Holding (OM:BONEX)10.4%59.4%
Bergen Carbon Solutions (OB:BCS)12%64.6%

Click here to see the full list of 218 stocks from our Fast Growing European Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

Ercros (BME:ECR)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Ercros, S.A. is a Spanish company that manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals with a market cap of €246.88 million.

Operations: Ercros generates revenue through its key segments: Pharmaceuticals (€64.49 million), Chlorine Derivatives (€378.78 million), and Intermediate Chemicals (€186.56 million).

Insider Ownership: 15.9%

Earnings Growth Forecast: 101.8% p.a.

Ercros is forecast to become profitable over the next three years, indicating above-average market growth potential. Despite trading at a good value compared to peers, its recent volatility and net loss of €29.27 million in H1 2025 raise concerns. The company's revenue is expected to grow faster than the Spanish market but remains below 20% annually. Ercros was recently dropped from the S&P Global BMI Index, and an acquisition attempt by Esseco Industrial was canceled in August 2025.

BME:ECR Ownership Breakdown as at Oct 2025

CTT Systems (OM:CTT)

Simply Wall St Growth Rating: ★★★★★★

Overview: CTT Systems AB (publ) specializes in providing humidity control systems for aircraft across various countries including Sweden, Denmark, France, and the United States, with a market cap of SEK2.78 billion.

Operations: The company generates revenue primarily from its Aerospace & Defense segment, which amounts to SEK275.10 million.

Insider Ownership: 17.5%

Earnings Growth Forecast: 37.9% p.a.

CTT Systems is poised for significant growth, with earnings expected to rise 37.87% annually, outpacing the Swedish market. Revenue is also forecast to grow rapidly at 24.7% per year. Despite lower profit margins compared to last year and a dividend not well covered by earnings, CTT's return on equity is projected to be very high in three years. Recent earnings showed a decline in net income and sales, but insider ownership remains substantial without recent selling activity.

OM:CTT Earnings and Revenue Growth as at Oct 2025

Smart Eye (OM:SEYE)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Smart Eye AB (publ) develops AI technology solutions to understand, support, and predict human behavior across the Nordics, Europe, North America, Asia, and internationally with a market cap of SEK3.23 billion.

Operations: Smart Eye's revenue segments include Behavioral Research at SEK249.10 million and Automotive Solutions at SEK112.45 million.

Insider Ownership: 15.2%

Earnings Growth Forecast: 104.2% p.a.

Smart Eye is positioned for robust growth, with revenue expected to increase by 46.1% annually, surpassing the Swedish market. The company recently secured a contract to supply its DMS technology to a North American EV platform, enhancing future prospects. Despite reporting a net loss of SEK 37.44 million in Q2 2025, losses have narrowed compared to the previous year. Trading at 58.8% below estimated fair value and with no recent insider selling, it remains an interesting investment consideration amidst high growth expectations and substantial insider ownership.

OM:SEYE Earnings and Revenue Growth as at Oct 2025

Taking Advantage

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're here to simplify it.

Discover if Ercros might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com